AstraZeneca bringing rare disease medicine to patients in China - BioPharma-Reporter

Retrieved on: 2022-11-14 18:22:21

Tags for this article:

Medical specialties

Medicine

Rare diseases

Organ systems

Blood disorders

Acquired hemolytic anemia

Autoimmune diseases

Atypical hemolytic uremic syndrome

Syndromes

Eculizumab

Paroxysmal nocturnal hemoglobinuria

Hemolytic–uremic syndrome

Soliris

Click the tags to see associated articles and topics

AstraZeneca bringing rare disease medicine to patients in China - BioPharma-Reporter. View article details on HISWAI: https://www.biopharma-reporter.com/Article/2022/11/14/astrazeneca-bringing-rare-disease-medicine-to-patients-in-china

Excerpt

The drug is designed to inhibit the C5 protein in the terminal complement cascade, a part of the body's immune system. When activated in an ...

Article found on: www.biopharma-reporter.com

View Original Article